Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.660
-0.190 (-10.27%)
At close: Apr 1, 2025, 4:00 PM
1.703
+0.042 (2.56%)
After-hours: Apr 1, 2025, 7:59 PM EDT
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $10.40 million as of April 1, 2025. Its market cap has decreased by -54.81% in one year.
Market Cap
10.40M
Enterprise Value
4.45M
1-Year Change
-54.81%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $10.40M, a decrease of -94.58%. That is a compound annual growth rate of -50.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 11.59M | 133.77% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |